Fluralaner

Verify with FDA CVM →

3,442 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
3,442
Total Reports
205
Deaths Reported
600.0%
Death Rate

Active Ingredients

Fluralaner

Administration Routes

OralUnknownTopicalOtherDentalIntragastricTransdermalSubcutaneous

Species Affected

Dog 3,283
Cat 154
Unknown 3
Other Canids 1
Goat 1

Most Affected Breeds

Retriever - Labrador 453
Retriever - Golden 187
Crossbred Canine/dog 164
Shepherd Dog - German 134
Shepherd Dog - Australian 114
Chihuahua 110
Shih Tzu 106
Dog (unknown) 104
Domestic Shorthair 98
Pit Bull 96

Most Reported Reactions

Vomiting 880
Lack of efficacy (endoparasite) - heartworm 432
Lethargy (see also Central nervous system depression in 'Neurological') 361
Diarrhoea 296
Other abnormal test result NOS 206
Seizure NOS 179
Weight loss 138
Not eating 135
Anorexia 122
Behavioural disorder NOS 110
INEFFECTIVE, HOOKS 110
Death 101

Outcome Breakdown

Outcome Unknown
1,430 (41.7%)
Recovered/Normal
906 (26.4%)
Ongoing
861 (25.1%)
Died
110 (3.2%)
Euthanized
95 (2.8%)
Recovered with Sequela
29 (0.8%)

Data Summary

Metric Value
Total adverse event reports 3,442
Reports involving death 205
Case-fatality rate (reported events) 600.0%
Distinct species in reports 5
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fluralaner Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 3,442 adverse event reports referencing Fluralaner, including 205 reports in which the animal died — a 600.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fluralaner. Reported administration routes include Oral, Unknown, Topical, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fluralaner reports are Dog (3,283 reports), Cat (154 reports), Unknown (3 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (453), Retriever - Golden (187), Crossbred Canine/dog (164) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fluralaner are Vomiting (880), Lack of efficacy (endoparasite) - heartworm (432), Lethargy (see also Central nervous system depression in 'Neurological') (361), Diarrhoea (296). Of the 3,431 reports with a coded outcome, Outcome Unknown is the leading category at 41.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fluralaner.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial